We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 13, 2020

The Hazard of Higher Doses of Anticoagulants in Non-Critically Ill Patients With COVID-19

Journal of Thrombosis and Haemostasis (JTH)


Additional Info

Journal of Thrombosis and Haemostasis (JTH)
The Hazard of (Sub)Therapeutic Doses of Anticoagulants in Non-Critically Ill Patients With Covid-19: The Padua Province Experience
J. Thromb. Haemost. 2020 Jul 21;[EPub Ahead of Print], R Pesavento, D Ceccato, G Pasquetto, J Monticelli, L Leone, A Frigo, D Gorgi, A Postal, GM Marchese, A Cipriani, A Saller, C Sarais, P Criveller, M Gemelli, F Capone, P Fioretto, C Pagano, M Rossato, A Avogaro, P Simioni, P Prandoni, R Vettor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading